Engineers Gate Manager LP Allakos Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$2.6 - $6.14 $3,790 - $8,952
1,458 Added 12.68%
12,959 $41,000
Q1 2022

May 16, 2022
SELL
$5.08 - $9.81 $90,048 - $173,892
-17,726 Reduced 60.65%
11,501 $66,000
Q4 2021

Feb 14, 2022
BUY
$8.55 - $111.89 $249,890 - $3.27 Million
29,227 New
29,227 $286,000

Others Institutions Holding ALLK

# of Institutions
81
Shares Held
64.7M
Call Options Held
47.1K
Put Options Held
1K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $108M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email